Skip to main content

Table 2 Demographic characteristics of 279 medical cannabis patients, by symptom group

From: Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic

 

Sample size (percentage)

Number of female patients (percentage)

Mean age (SD)

Overall sample

279

190 (68)

61.1 (16.6)

Moderate or severe pain symptom group

205 (73.5)

150 (73)

61.8 (15.9)

Moderate or severe anxiety symptom group

138 (48.5)

97 (70)

61.43 (16.3)

Moderate or severe depression symptom group

115 (41.2)

81 (70)

60.5 (15)

Moderate or severe wellbeing group

202 (72.4)

141 (70)

60.8 (16.1)

CBD/THC:CBD group

116 (41.6)

75 (65)

60.38 (14.4)

  1. The symptom groups are mild and moderate or severe. The table presents the moderate or severe demographic characteristics. The CBD/THC:CBD group is composed of patients who added THC to their CBD-rich prescription during FUP1
  2. CBD cannabidiol, THC Δ9-tetrahydrocannabinol, SD standard deviation